← Leaderboards
Dino Di Carlo
University Of California Los Angeles
$8,576,900
Attributed
$14,081,007
Total exposure
14
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2010–25$2.5M$1.9M$1.3M$625K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,081,007 · 14
By mechanism
R44$5,256,972 · 2
DP2$2,310,000 · 1
R21$2,290,867 · 6
R01$1,776,119 · 2
T32$1,642,083 · 1
R33$718,565 · 1
Top collaborators
- Paul Michael Arnaboldi7 shared
- Azita Emami6 shared
- Tzung K Hsiai6 shared
- Yu-Chong Tai5 shared
- Yi Tang3 shared
- Raymond James Dattwyler2 shared
- Bahram Jalali2 shared
- Reynold Alexander Panettieri2 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Yi Tang$19,359,331
- Kendall N Houk$14,756,097
- Bahram Jalali$759,642
Others in their field
Top investigators on “Technology”
- David Heimbrook · Leidos Biomedical Research, Inc.$995,338,451
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Eric S Lander · Whitehead Institute For Biomedical Res$606,570,095
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Richard K. Wilson · Washington University$441,856,657
Research focus
TechnologyCellsBaseEngineeringDesignCostDiagnosticSignal TransductionSamplingInterestLaboratoriesScreeningDetectionAntibodiesPublic Health RelevanceReportingMicrofluidicsParticlePathway InteractionsGenerationsResearch PersonnelPharmaceutical PreparationsNext GenerationPrevent
Grant awards (37)
A point of care vertical flow assay for the direct detection of Babesia microti and the serodiagnosis of Lyme disease.$962,204
R44 · FY2025 · AI
Sorting high extracellular vesicle secretors for optimal cell therapy$729,703
R01 · FY2025 · HL
Caltech/UCLA Individualized Theranostic Engineering to Advance Metabolic System (iTEAM)$343,974
T32 · FY2025 · EB
Engineering Yeast towards High Titer Production of Monoterpene Indole Alkaloid Natural Products$327,390
R01 · FY2025 · AT
A point of care vertical flow assay for the direct detection of Babesia microti and the serodiagnosis of Lyme disease.$971,664
R44 · FY2024 · AI
Engineering Yeast towards High Titer Production of Monoterpene Indole Alkaloid Natural Products$356,249
R01 · FY2024 · AT
Caltech/UCLA Individualized Theranostic Engineering to Advance Metabolic System (iTEAM)$278,142
T32 · FY2024 · EB
A peptide-based point-of-care vertical flow assay for the rapid diagnosis of Lyme disease$971,240
R44 · FY2023 · AI
Engineering Yeast towards High Titer Production of Monoterpene Indole Alkaloid Natural Products$362,777
R01 · FY2023 · AT
Caltech/UCLA Individualized Theranostic Engineering to Advance Metabolic System (iTEAM)$287,887
T32 · FY2023 · EB
Training the next generation of leaders in biomedical engineering design$1
R25 · FY2023 · EB · contact PI
A peptide-based point-of-care vertical flow assay for the rapid diagnosis of Lyme disease$986,480
R44 · FY2022 · AI
Lab on a particle technology for functional screening of therapeutic cells$246,355
R21 · FY2022 · CA · contact PI
Hydrogel nanovial technology for single-cell sorting based on extracellular vesicle production$214,517
R21 · FY2022 · GM · contact PI
Caltech/UCLA Individualized Theranostic Engineering to Advance Metabolic System (iTEAM)$154,561
T32 · FY2022 · EB
A peptide-based point-of-care vertical flow assay for the rapid diagnosis of Lyme disease$65,384
R44 · FY2022 · AI
Training the next generation of leaders in biomedical engineering design$21,600
R25 · FY2022 · EB · contact PI
A peptide-based point-of-care vertical flow assay for the rapid diagnosis of Lyme disease$1,000,000
R44 · FY2021 · AI
Caltech/UCLA Individualized Theranostic Engineering to Advance Metabolic System (iTEAM)$291,889
T32 · FY2021 · EB
Lab on a particle technology for functional screening of therapeutic cells$263,241
R21 · FY2021 · CA · contact PI
Enhancing the potency of mesenchymal stem cell therapies for kidney diseases using lab-on-a-particle technology$185,208
R21 · FY2021 · DK · contact PI
Hydrogel nanovial technology for single-cell sorting based on extracellular vesicle production$176,084
R21 · FY2021 · GM · contact PI
Training the next generation of leaders in biomedical engineering design$21,600
R25 · FY2021 · EB · contact PI
A peptide-based point-of-care vertical flow assay for the rapid diagnosis of Lyme disease$300,000
R44 · FY2020 · AI
Caltech/UCLA Individualized Theranostic Engineering to Advance Metabolic System (iTEAM)$285,630
T32 · FY2020 · EB
Training the next generation of leaders in biomedical engineering design$21,600
R25 · FY2020 · EB · contact PI
Training the next generation of leaders in biomedical engineering design$21,600
R25 · FY2019 · EB · contact PI
Force phenotyping of airway smooth muscle cells to develop novel asthma therapies$234,750
R21 · FY2018 · EB · contact PI
Particle-drops for democratization of digital assays$184,860
R21 · FY2018 · GM · contact PI
Force phenotyping of airway smooth muscle cells to develop novel asthma therapies$209,125
R21 · FY2017 · EB · contact PI
Particle-drops for democratization of digital assays$153,227
R21 · FY2017 · GM · contact PI
A Frequency-multiplexed flow cytometer for high throughput screening and drug discovery$231,000
R21 · FY2016 · EB · contact PI
Isolating circulating tumor cells using a centrifuge on a chip$246,971
R33 · FY2015 · CA · contact PI
A Frequency-multiplexed flow cytometer for high throughput screening and drug discovery$192,500
R21 · FY2015 · EB · contact PI
Isolating circulating tumor cells using a centrifuge on a chip$243,781
R33 · FY2014 · CA · contact PI
Isolating circulating tumor cells using a centrifuge on a chip$227,813
R33 · FY2013 · CA · contact PI
Engineering the Intracellular Micro- and Nanoenvironment$2,310,000
DP2 · FY2010 · OD · contact PI